Educational only — not medical advice. If you’re in crisis or thinking about suicide: call or text 988 (U.S.) or your local emergency number. Support resources. Under construction and review—see the updates log.
Brands: ADDERALL, ADDERALL XR, MYDAYIS
Published 2026-02-13 · Last reviewed 2026-02-20 · 5 references
Content sourced from FDA labeling (DailyMed) and peer-reviewed literature.
Amphetamine/dextroamphetamine (mixed amphetamine salts) is a Schedule II stimulant used as a first-line medication option for ADHD. Benefits are best assessed in functional terms (task completion, fewer mistakes, improved driving attention) rather than subjective “energy.”
Formulation selection determines onset and duration. Immediate-release products emphasize flexibility, while extended-release products provide once-daily morning dosing and reduce midday dosing burden.
In serious mental illness, stimulants can worsen insomnia, anxiety, irritability, mania, or psychosis in susceptible patients. Clinicians typically confirm ADHD diagnosis, ensure mood/psychosis is stable first, and titrate conservatively with close follow-up.
The amphetamine/dextroamphetamine compare view, the evidence feed, and the print page can support shared decision-making about safe use and monitoring.
Common pitfalls are late-day dosing that disrupts sleep, titration that ignores appetite loss and anxiety, and under-recognition of substance use or bipolar spectrum illness. Success depends on matching duration to the impairment window and monitoring for cardiovascular and psychiatric activation.
View labelExactRefer to the Glossary entry on Neurotransmitters for background on receptor systems involved in serious mental illness.
Promotes release of dopamine and norepinephrine and also inhibits reuptake, increasing catecholamine signaling in circuits relevant to attention and impulse control.
Clinical benefit can be rapid; measure response with concrete targets (work output, fewer errors, less impulsive behavior) and reassess after each dose change.
Because it is activating, it can worsen insomnia and anxiety when dosing is late or titration is too aggressive.
Sources: DailyMed label(s); guideline statements; network meta-analysis context.